首页 > 最新文献

Therapeutics and Clinical Risk Management最新文献

英文 中文
Airway Organoid Models as Pivotal Tools for Unraveling Molecular Mechanisms and Therapeutic Targets in Respiratory Diseases: A Literature Review. 气道类器官模型作为揭示呼吸系统疾病分子机制和治疗靶点的关键工具:文献综述
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-24 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S526727
Shu-Ping Jiang, Bing-Qi Lin, Xing-Qiang Zhou, Min-Hua Li, Zhen-Cheng Feng, Yue-Ying Qin, Shi-Qi Lin, Zi-Qing Zhou, Yang Peng, Lian Li

Respiratory inflammatory and infectious diseases continue to impose a substantial global health burden, compounded by persistent gaps in understanding their pathogenic mechanisms and limited therapeutic advancements. To address these challenges, this review systematically analyzed literature from PubMed, Web of Science, and Scopus databases (2005-2025) to evaluate the evolution and applications of airway organoid models in respiratory disease research. Key findings include: (1) the convergence of traditional culture techniques with advanced methodologies - including 3D matrix embedding, bioprinting and organoids-on-chips technologies - has enabled unprecedented recapitulation of human airway architecture and multicellular interactions; (2) these novel models provide unique insights into disease pathogenesis, host-microbe dynamics, and drug response variability; (3) the inherent capacity to maintain native cellular diversity and disease-associated phenotypes positions airway organoids as crucial platforms for personalized medicine approaches. Collectively, these advances establish airway organoids as transformative tools that bridge conventional in vitro models and clinical reality. Looking ahead, coupling organs-on-chips platforms with microgravity culture and single-cell lineage tracing will catalyze fundamental breakthroughs in respiratory disease research.

呼吸道炎症和传染病继续给全球健康造成沉重负担,对其致病机制的了解持续存在差距,治疗进展有限,使情况更加复杂。为了应对这些挑战,本综述系统地分析了PubMed、Web of Science和Scopus数据库(2005-2025)的文献,以评估气道类器官模型在呼吸系统疾病研究中的发展和应用。主要发现包括:(1)传统培养技术与先进方法的融合——包括3D基质嵌入、生物打印和类器官芯片技术——使人类气道结构和多细胞相互作用的重现成为可能;(2)这些新模型为疾病发病机制、宿主-微生物动力学和药物反应变异性提供了独特的见解;(3)维持天然细胞多样性和疾病相关表型的固有能力使气道类器官成为个性化医疗方法的重要平台。总的来说,这些进展使气道类器官成为连接传统体外模型和临床现实的变革性工具。展望未来,将器官芯片平台与微重力培养和单细胞谱系追踪相结合,将催化呼吸系统疾病研究取得根本性突破。
{"title":"Airway Organoid Models as Pivotal Tools for Unraveling Molecular Mechanisms and Therapeutic Targets in Respiratory Diseases: A Literature Review.","authors":"Shu-Ping Jiang, Bing-Qi Lin, Xing-Qiang Zhou, Min-Hua Li, Zhen-Cheng Feng, Yue-Ying Qin, Shi-Qi Lin, Zi-Qing Zhou, Yang Peng, Lian Li","doi":"10.2147/TCRM.S526727","DOIUrl":"10.2147/TCRM.S526727","url":null,"abstract":"<p><p>Respiratory inflammatory and infectious diseases continue to impose a substantial global health burden, compounded by persistent gaps in understanding their pathogenic mechanisms and limited therapeutic advancements. To address these challenges, this review systematically analyzed literature from PubMed, Web of Science, and Scopus databases (2005-2025) to evaluate the evolution and applications of airway organoid models in respiratory disease research. Key findings include: (1) the convergence of traditional culture techniques with advanced methodologies - including 3D matrix embedding, bioprinting and organoids-on-chips technologies - has enabled unprecedented recapitulation of human airway architecture and multicellular interactions; (2) these novel models provide unique insights into disease pathogenesis, host-microbe dynamics, and drug response variability; (3) the inherent capacity to maintain native cellular diversity and disease-associated phenotypes positions airway organoids as crucial platforms for personalized medicine approaches. Collectively, these advances establish airway organoids as transformative tools that bridge conventional in vitro models and clinical reality. Looking ahead, coupling organs-on-chips platforms with microgravity culture and single-cell lineage tracing will catalyze fundamental breakthroughs in respiratory disease research.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"975-986"},"PeriodicalIF":2.8,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tranexamic Acid Demonstrated a Trend Toward Decreased Perioperative Blood Loss in Posterior Decompression Surgery of Patient with Metastatic Spinal Tumor. 氨甲环酸可减少转移性脊柱肿瘤后路减压术患者围手术期出血量。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-21 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S516261
Yunpeng Cui, Huaijin Li, Chuan Mi, Bing Wang, Yuanxing Pan, Wei Yu, Xuedong Shi

Background: To explore the effect of tranexamic acid (TXA) on perioperative blood loss in posterior decompression surgery of patient with metastatic spinal tumor.

Methods: Three hundred sixty-eight consecutive patients between May 2011 and Aug 2022 were retrospectively reviewed. One hundred eighty patients (182 surgeries) met the criteria and were included in the study. Sixty-two surgeries received preoperative intravenous TXA (TXA group), and 120 did not (non-TXA group). The primary outcome was total blood loss. T-test, Mann-Whitney U, and chi-square tests were used to evaluate the difference in baseline data, total blood loss, and other outcome measures between the two groups.

Results: Patients with hyper vascular tumors had significantly more blood loss compared with non-hyper vascular tumors (2002(1531,2792) mL vs 1469(1036,1962) mL, p=0.001). There was no significant different in the postoperative venous thromboembolism of the lower limb between the two groups. For patients with non-hyper vascular tumors, the blood loss (1216(827, 1709) mL vs 1561(1146, 2019) mL, p = 0.012) and postoperative drainage (1-day post-operation: 240(150,290) mL vs 280(150,395) mL, p=0.040; 3-days post-operation: 450(348,630) mL vs 613(398,799) mL, p=0.025) of TXA group were significantly less compared with that of the non-TXA group. Meanwhile, the TXA group had significantly less postoperative hospitalization compared with the non-TXA group (11.0(9.0, 13.3) days vs 12.5(9.0, 16.3) days, p=0.023). For patients with hyper vascular tumors, there were no significant differences in the blood loss and amount of postoperative drainage between the two groups.

Conclusion: Preoperative intravenous TXA demonstrated a trend toward decreased perioperative blood loss in posterior decompression surgery of spinal metastases with non-hyper vascular tumors.

背景:探讨氨甲环酸(TXA)对脊柱转移性肿瘤后路减压围手术期出血量的影响。方法:对2011年5月至2022年8月期间连续368例患者进行回顾性分析。180例患者(182例手术)符合标准并纳入研究。术前静脉注射TXA 62例(TXA组),未注射TXA 120例(非TXA组)。主要结果是总失血量。采用t检验、Mann-Whitney U检验和卡方检验来评估两组之间基线数据、总失血量和其他结局指标的差异。结果:高血管肿瘤患者的失血量明显高于非高血管肿瘤患者(2002(1531,2792)mL vs 1469(1036,1962) mL, p=0.001)。两组患者术后下肢静脉血栓栓塞发生率无显著差异。对于非高血管肿瘤患者,出血量(1216(827,1709)mL vs 1561(1146,2019) mL, p= 0.012)和术后引流(术后1天:240(150,290)mL vs 280(150,395) mL, p=0.040;术后3 d: TXA组450(348,630)mL vs 613(398,799) mL, p=0.025)明显少于非TXA组。同时,与非TXA组相比,TXA组术后住院时间明显减少(11.0(9.0,13.3)天vs 12.5(9.0, 16.3)天,p=0.023)。对于高血管肿瘤患者,两组术后出血量和引流量无显著差异。结论:术前静脉注射TXA可减少脊柱转移性非高血管肿瘤后路减压术的围术期出血量。
{"title":"Tranexamic Acid Demonstrated a Trend Toward Decreased Perioperative Blood Loss in Posterior Decompression Surgery of Patient with Metastatic Spinal Tumor.","authors":"Yunpeng Cui, Huaijin Li, Chuan Mi, Bing Wang, Yuanxing Pan, Wei Yu, Xuedong Shi","doi":"10.2147/TCRM.S516261","DOIUrl":"10.2147/TCRM.S516261","url":null,"abstract":"<p><strong>Background: </strong>To explore the effect of tranexamic acid (TXA) on perioperative blood loss in posterior decompression surgery of patient with metastatic spinal tumor.</p><p><strong>Methods: </strong>Three hundred sixty-eight consecutive patients between May 2011 and Aug 2022 were retrospectively reviewed. One hundred eighty patients (182 surgeries) met the criteria and were included in the study. Sixty-two surgeries received preoperative intravenous TXA (TXA group), and 120 did not (non-TXA group). The primary outcome was total blood loss. <i>T</i>-test, Mann-Whitney U, and chi-square tests were used to evaluate the difference in baseline data, total blood loss, and other outcome measures between the two groups.</p><p><strong>Results: </strong>Patients with hyper vascular tumors had significantly more blood loss compared with non-hyper vascular tumors (2002(1531,2792) mL vs 1469(1036,1962) mL, p=0.001). There was no significant different in the postoperative venous thromboembolism of the lower limb between the two groups. For patients with non-hyper vascular tumors, the blood loss (1216(827, 1709) mL vs 1561(1146, 2019) mL, p = 0.012) and postoperative drainage (1-day post-operation: 240(150,290) mL vs 280(150,395) mL, p=0.040; 3-days post-operation: 450(348,630) mL vs 613(398,799) mL, p=0.025) of TXA group were significantly less compared with that of the non-TXA group. Meanwhile, the TXA group had significantly less postoperative hospitalization compared with the non-TXA group (11.0(9.0, 13.3) days vs 12.5(9.0, 16.3) days, p=0.023). For patients with hyper vascular tumors, there were no significant differences in the blood loss and amount of postoperative drainage between the two groups.</p><p><strong>Conclusion: </strong>Preoperative intravenous TXA demonstrated a trend toward decreased perioperative blood loss in posterior decompression surgery of spinal metastases with non-hyper vascular tumors.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"951-962"},"PeriodicalIF":2.8,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analysis of Prognostic Factors and Pregnancy Outcomes in Patients with Moderate-to-Severe Intrauterine Adhesions Following Hysteroscopic Adhesiolysis and Modified Intrauterine Stent Intervention. 宫腔镜下粘连松解及改良宫内支架介入后中重度宫内粘连患者预后因素及妊娠结局的回顾性分析
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-21 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S511425
Qiao Peng, Chao-Xia Cao, Yi-Nan Chen, Wei-Chu Liu, Rui-Kun Zhao, Quan-Jia Jiang, Qin Zhou

Objective: To assess the clinical prognosis and reproductive outcomes in individuals presenting with moderate-to-severe intrauterine adhesion (IUA) following the administration of hysteroscopic adhesiolysis (HA) in conjunction with modified intrauterine stents.

Methods: A cohort comprising 156 individuals diagnosed with IUA (105 with moderate severity and 51 with severe severity) was enrolled. Subsequent to hysteroscopic intervention, all participants received intrauterine stent placement during the immediate postoperative phase. A comprehensive follow-up period of 2 years post-stent removal was instituted.

Results: The occurrence of adhesion recurrence increased progressively, demonstrating a recurrence rate of 11.54% at hysteroscopic reevaluation administrated in 3 months after surgery and surging to 32.69% during the 2-year follow-up period. Comparative analysis indicated a statistically significant reduction in recurrence rates among patients with moderate IUA compared to severe IUA (P < 0.05). The median duration of stent placement was determined to be 4 months. Postoperatively, patients exhibited a cumulative pregnancy rate of 71.79%, with a live birth rate of 79.28%. Significantly, patients with moderate IUA exhibited a significantly elevated pregnancy rate in comparison to those with severe IUA (P = 0.004). Multifactorial logistic regression analysis revealed that the severity of IUA was an independent risk factor for recurrence risk. Furthermore, the severity of IUA and postoperative re-adhesion emerged as contributory factors to the infertility observed in these patients.

Conclusion: The combination of HA with a modified intrauterine stent demonstrates efficacy in the treatment of IUA; however, outcomes remain suboptimal for cases characterized by severity. The prognostic assessment of patients and the suggested criteria for the removal of intrauterine stents, as delineated in the study, are considered both feasible and recommendable for clinical practice. Furthermore, conscientious and attentive management is imperative for the mitigation of adverse pregnancy such as early pregnancy loss in individuals afflicted with IUA during pregnancy.

目的:评价宫腔镜下粘连松解术(HA)联合改良宫内支架治疗后出现中重度宫内粘连(IUA)的患者的临床预后和生殖结局。方法:纳入156例诊断为IUA的患者(105例为中度严重程度,51例为重度严重程度)。在宫腔镜干预后,所有参与者在术后立即接受宫内支架置入。支架取出后进行了为期2年的全面随访。结果:粘连复发的发生率逐渐增加,术后3个月宫腔镜复查复发率为11.54%,随访2年复发率为32.69%。对比分析显示,中度IUA患者的复发率较重度IUA患者降低有统计学意义(P < 0.05)。支架放置的中位持续时间为4个月。术后累计妊娠率为71.79%,活产率为79.28%。值得注意的是,中度IUA患者的妊娠率明显高于重度IUA患者(P = 0.004)。多因素logistic回归分析显示IUA严重程度是复发风险的独立危险因素。此外,IUA的严重程度和术后再粘连是导致这些患者不孕的因素。结论:HA联合改良宫内支架治疗IUA疗效显著;然而,对于以严重程度为特征的病例,结果仍然不理想。研究中所描述的患者预后评估和宫内支架移除的建议标准被认为是可行的,值得临床实践。此外,认真和细心的管理是必要的,以减轻不良妊娠,如早期妊娠损失的个人在怀孕期间患有IUA。
{"title":"Retrospective Analysis of Prognostic Factors and Pregnancy Outcomes in Patients with Moderate-to-Severe Intrauterine Adhesions Following Hysteroscopic Adhesiolysis and Modified Intrauterine Stent Intervention.","authors":"Qiao Peng, Chao-Xia Cao, Yi-Nan Chen, Wei-Chu Liu, Rui-Kun Zhao, Quan-Jia Jiang, Qin Zhou","doi":"10.2147/TCRM.S511425","DOIUrl":"10.2147/TCRM.S511425","url":null,"abstract":"<p><strong>Objective: </strong>To assess the clinical prognosis and reproductive outcomes in individuals presenting with moderate-to-severe intrauterine adhesion (IUA) following the administration of hysteroscopic adhesiolysis (HA) in conjunction with modified intrauterine stents.</p><p><strong>Methods: </strong>A cohort comprising 156 individuals diagnosed with IUA (105 with moderate severity and 51 with severe severity) was enrolled. Subsequent to hysteroscopic intervention, all participants received intrauterine stent placement during the immediate postoperative phase. A comprehensive follow-up period of 2 years post-stent removal was instituted.</p><p><strong>Results: </strong>The occurrence of adhesion recurrence increased progressively, demonstrating a recurrence rate of 11.54% at hysteroscopic reevaluation administrated in 3 months after surgery and surging to 32.69% during the 2-year follow-up period. Comparative analysis indicated a statistically significant reduction in recurrence rates among patients with moderate IUA compared to severe IUA (P < 0.05). The median duration of stent placement was determined to be 4 months. Postoperatively, patients exhibited a cumulative pregnancy rate of 71.79%, with a live birth rate of 79.28%. Significantly, patients with moderate IUA exhibited a significantly elevated pregnancy rate in comparison to those with severe IUA (P = 0.004). Multifactorial logistic regression analysis revealed that the severity of IUA was an independent risk factor for recurrence risk. Furthermore, the severity of IUA and postoperative re-adhesion emerged as contributory factors to the infertility observed in these patients.</p><p><strong>Conclusion: </strong>The combination of HA with a modified intrauterine stent demonstrates efficacy in the treatment of IUA; however, outcomes remain suboptimal for cases characterized by severity. The prognostic assessment of patients and the suggested criteria for the removal of intrauterine stents, as delineated in the study, are considered both feasible and recommendable for clinical practice. Furthermore, conscientious and attentive management is imperative for the mitigation of adverse pregnancy such as early pregnancy loss in individuals afflicted with IUA during pregnancy.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"929-939"},"PeriodicalIF":2.8,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12191175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Study on the Effect of STA Anesthesia Technique in the Extraction of Impacted Teeth in Dental Outpatients and Its Impact on Patient Anxiety Levels. STA麻醉技术在牙科门诊阻生牙拔除中的效果及其对患者焦虑水平影响的回顾性研究
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-21 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S523718
Jie Xu, Junsen Su, Guangfeng Liu, Wanggui Ying, Fang Yuan

Objective: To analyze the effect of the Single Tooth Anesthesia (STA) technique in dental outpatient patients undergoing the extraction of impacted teeth and its impact on patient anxiety levels.

Methods: This retrospective study included clinical data from 130 patients who underwent the extraction of a single mandibular impacted tooth in our dental outpatient department between April 2022 and June 2024. According to the anesthesia method, patients were divided into two groups: the Traditional Group (n = 65, receiving traditional local injection anesthesia) and the STA Group (n = 65, receiving Single Tooth Anesthesia). Parameters including intraoperative bleeding, duration of anesthesia, extent of anesthetic infiltration, blood pressure [systolic blood pressure (SBP), diastolic blood pressure (DBP)], heart rate (HR), pain [visual analog scale (VAS)], compliance (Frankl treatment compliance scale), tolerance (Houpt behavior scale), and anxiety level [modified dental anxiety scale (MDAS)] were compared between the two groups.

Results: There were no significant differences in the amount of bleeding, anesthesia duration, or infiltration range between the two groups (P > 0.05). In the Traditional Group, SBP at 3 minutes after anesthesia and post-extraction was significantly higher than before anesthesia (P < 0.05), whereas DBP and HR showed no significant changes (P > 0.05). In the STA Group, SBP, DBP, and HR remained stable across the three time points (P > 0.05). Compared with the Traditional Group, the STA Group showed significantly lower pain scores, reduced anxiety, and higher rates of treatment compliance and tolerance (P < 0.05).

Conclusion: Within the limitations of this retrospective study, the STA anesthesia technique showed advantages over traditional local injection anesthesia in reducing pain and anxiety, while improving compliance and tolerance during impacted tooth extraction in dental outpatients.

目的:分析单牙麻醉(STA)技术在牙科门诊阻生牙拔除术中的应用效果及其对患者焦虑水平的影响。方法:本回顾性研究纳入了2022年4月至2024年6月在我院牙科门诊接受单侧下颌阻生牙拔除的130例患者的临床资料。根据麻醉方式将患者分为两组:传统组(65例,采用传统局部注射麻醉)和STA组(65例,采用单牙麻醉)。比较两组患者术中出血、麻醉持续时间、麻醉浸润程度、血压[收缩压(SBP)、舒张压(DBP)]、心率(HR)、疼痛[视觉模拟量表(VAS)]、依从性(Frankl治疗依从性量表)、耐受性(Houpt行为量表)、焦虑水平[改良牙科焦虑量表(MDAS)]等参数。结果:两组患者出血量、麻醉时间、浸润范围比较,差异均无统计学意义(P < 0.05)。传统组麻醉后3分钟收缩压及拔牙后收缩压均明显高于麻醉前(P < 0.05),舒张压、心率无明显变化(P < 0.05)。STA组收缩压、舒张压和心率在三个时间点保持稳定(P < 0.05)。与传统组比较,STA组疼痛评分明显降低,焦虑程度明显降低,治疗依从性和耐受性明显提高(P < 0.05)。结论:在本回顾性研究的局限性内,STA麻醉技术在减轻牙科门诊患者阻生拔牙时的疼痛和焦虑,同时提高依从性和耐受性方面优于传统的局部注射麻醉。
{"title":"A Retrospective Study on the Effect of STA Anesthesia Technique in the Extraction of Impacted Teeth in Dental Outpatients and Its Impact on Patient Anxiety Levels.","authors":"Jie Xu, Junsen Su, Guangfeng Liu, Wanggui Ying, Fang Yuan","doi":"10.2147/TCRM.S523718","DOIUrl":"10.2147/TCRM.S523718","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the effect of the Single Tooth Anesthesia (STA) technique in dental outpatient patients undergoing the extraction of impacted teeth and its impact on patient anxiety levels.</p><p><strong>Methods: </strong>This retrospective study included clinical data from 130 patients who underwent the extraction of a single mandibular impacted tooth in our dental outpatient department between April 2022 and June 2024. According to the anesthesia method, patients were divided into two groups: the Traditional Group (n = 65, receiving traditional local injection anesthesia) and the STA Group (n = 65, receiving Single Tooth Anesthesia). Parameters including intraoperative bleeding, duration of anesthesia, extent of anesthetic infiltration, blood pressure [systolic blood pressure (SBP), diastolic blood pressure (DBP)], heart rate (HR), pain [visual analog scale (VAS)], compliance (Frankl treatment compliance scale), tolerance (Houpt behavior scale), and anxiety level [modified dental anxiety scale (MDAS)] were compared between the two groups.</p><p><strong>Results: </strong>There were no significant differences in the amount of bleeding, anesthesia duration, or infiltration range between the two groups (P > 0.05). In the Traditional Group, SBP at 3 minutes after anesthesia and post-extraction was significantly higher than before anesthesia (P < 0.05), whereas DBP and HR showed no significant changes (P > 0.05). In the STA Group, SBP, DBP, and HR remained stable across the three time points (P > 0.05). Compared with the Traditional Group, the STA Group showed significantly lower pain scores, reduced anxiety, and higher rates of treatment compliance and tolerance (P < 0.05).</p><p><strong>Conclusion: </strong>Within the limitations of this retrospective study, the STA anesthesia technique showed advantages over traditional local injection anesthesia in reducing pain and anxiety, while improving compliance and tolerance during impacted tooth extraction in dental outpatients.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"941-950"},"PeriodicalIF":2.8,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12191143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Onset-to-Needle Time on the Risk of Early Neurological Deterioration in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis. 静脉溶栓对急性缺血性脑卒中患者早期神经功能恶化风险的影响
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-19 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S515542
Bo Hu, Jiewei Hua

Objective: This study aimed to investigate the influence of onset-to-needle time (ONT) on early neurological deterioration (END) in patients with acute ischemic stroke (AIS) undergoing intravenous thrombolysis.

Methods: Patients with AIS receiving intravenous thrombolysis at The Fifth Hospital of Wuhan between March 2021 and December 2023 were enrolled. Patients were divided into an END group (n=104) and a non-END group (n=317) based on a National Institutes of Health Stroke Scale (NIHSS) score increase of ≥4 points within 24 hours. Baseline and clinical data were analyzed using univariate, multivariable logistic regression, and subgroup analyses. A logistic regression model was developed to predict END, and its performance was assessed using receiver operating characteristic (ROC) curves.

Results: Univariate analysis revealed significant differences between groups in age, total cholesterol, low-density lipoprotein cholesterol (LDL-C), lipoprotein-associated phospholipase A2 (Lp-PLA2), white blood cell count, activated partial thromboplastin time (APTT), pre-admission NIHSS score, and ONT (all P<0.05). Heart disease history, infarct location, and Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification also differed significantly (all P<0.05). Multivariable analysis identified age (Odds Ratio [OR]=1.098, 95% Confidence Interval [CI]: 1.031-1.169, P=0.003), LDL-C (OR=2.785, 95% CI: 1.360-5.710, P=0.005), Lp-PLA2 (OR=1.008, 95% CI: 1.001-1.015, P=0.045), complete anterior circulation infarction (vs lacunar; OR=8.050, 95% CI: 5.180-12.510, P=0.023), cardioembolic stroke (vs small vessel occlusion; OR=12.810, 95% CI: 8.420-19.530, P=0.002), and ONT (OR=1.015, 95% CI: 1.002-1.028, P=0.028) as independent risk factors for END. Subgroup analysis by admission NIHSS score showed that for moderate and severe strokes, each minute increase in ONT raised END risk by 1.5% (95% CI: 1.002-1.028, P=0.031) and 3.0% (95% CI: 1.009-1.052, P=0.005), respectively.

Conclusion: Prolonged ONT is an independent risk factor for END in AIS patients, particularly those with moderate to severe strokes. Prompt thrombolysis is crucial for mitigating neurological decline.

目的:探讨急性缺血性脑卒中(AIS)患者静脉溶栓后,起病到针时间(ONT)对早期神经功能恶化(END)的影响。方法:选取2021年3月至2023年12月在武汉市第五医院接受静脉溶栓治疗的AIS患者。根据美国国立卫生研究院卒中量表(NIHSS)评分在24小时内升高≥4分,将患者分为END组(n=104)和非END组(n=317)。基线和临床资料采用单因素、多因素logistic回归和亚组分析进行分析。建立logistic回归模型预测END,并使用受试者工作特征(ROC)曲线评估其性能。结果:单因素分析显示,年龄、总胆固醇、低密度脂蛋白胆固醇(LDL-C)、脂蛋白相关磷脂酶A2 (Lp-PLA2)、白细胞计数、活化的部分凝血酶时间(APTT)、入院前NIHSS评分和ONT(均为p)组间存在显著差异。结论:ONT延长是AIS患者,特别是中重度卒中患者发生END的独立危险因素。及时溶栓对缓解神经功能衰退至关重要。
{"title":"Impact of Onset-to-Needle Time on the Risk of Early Neurological Deterioration in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis.","authors":"Bo Hu, Jiewei Hua","doi":"10.2147/TCRM.S515542","DOIUrl":"10.2147/TCRM.S515542","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the influence of onset-to-needle time (ONT) on early neurological deterioration (END) in patients with acute ischemic stroke (AIS) undergoing intravenous thrombolysis.</p><p><strong>Methods: </strong>Patients with AIS receiving intravenous thrombolysis at The Fifth Hospital of Wuhan between March 2021 and December 2023 were enrolled. Patients were divided into an END group (n=104) and a non-END group (n=317) based on a National Institutes of Health Stroke Scale (NIHSS) score increase of ≥4 points within 24 hours. Baseline and clinical data were analyzed using univariate, multivariable logistic regression, and subgroup analyses. A logistic regression model was developed to predict END, and its performance was assessed using receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>Univariate analysis revealed significant differences between groups in age, total cholesterol, low-density lipoprotein cholesterol (LDL-C), lipoprotein-associated phospholipase A2 (Lp-PLA2), white blood cell count, activated partial thromboplastin time (APTT), pre-admission NIHSS score, and ONT (all P<0.05). Heart disease history, infarct location, and Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification also differed significantly (all P<0.05). Multivariable analysis identified age (Odds Ratio [OR]=1.098, 95% Confidence Interval [CI]: 1.031-1.169, P=0.003), LDL-C (OR=2.785, 95% CI: 1.360-5.710, P=0.005), Lp-PLA2 (OR=1.008, 95% CI: 1.001-1.015, P=0.045), complete anterior circulation infarction (vs lacunar; OR=8.050, 95% CI: 5.180-12.510, P=0.023), cardioembolic stroke (vs small vessel occlusion; OR=12.810, 95% CI: 8.420-19.530, P=0.002), and ONT (OR=1.015, 95% CI: 1.002-1.028, P=0.028) as independent risk factors for END. Subgroup analysis by admission NIHSS score showed that for moderate and severe strokes, each minute increase in ONT raised END risk by 1.5% (95% CI: 1.002-1.028, P=0.031) and 3.0% (95% CI: 1.009-1.052, P=0.005), respectively.</p><p><strong>Conclusion: </strong>Prolonged ONT is an independent risk factor for END in AIS patients, particularly those with moderate to severe strokes. Prompt thrombolysis is crucial for mitigating neurological decline.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"917-927"},"PeriodicalIF":2.8,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184684/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144476755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-Assisted 3D Planning of CT Parameters for Personalized Femoral Prosthesis Selection in Total Hip Arthroplasty. 人工智能辅助下全髋关节置换术中股骨假体个性化选择的CT参数三维规划
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-18 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S521755
Tian-Jiao Yang, Wei Qian

Objective: To investigate the efficacy of CT measurement parameters combined with AI-assisted 3D planning for personalized femoral prosthesis selection in total hip arthroplasty (THA).

Methods: A retrospective analysis was conducted on clinical data from 247 patients with unilateral hip or knee joint disorders treated at Renmin Hospital of Hubei University of Medicine between April 2021 and February 2024. All patients underwent preoperative full-pelvis and bilateral full-length femoral CT scans. The raw CT data were imported into Mimics 19.0 software to reconstruct a three-dimensional (3D) model of the healthy femur. Using 3-matic Research 11.0 software, the femoral head rotation center was located, and parameters including femoral head diameter (FHD), femoral neck length (FNL), femoral neck-shaft angle (FNSA), femoral offset (FO), femoral neck anteversion angle (FNAA), tip-apex distance (TAD), and tip-apex angle (TAA) were measured. AI-assisted THA 3D planning system AIJOINT V1.0.0.0 software was used for preoperative planning and design, enabling personalized selection of femoral prostheses with varying neck-shaft angles and surgical simulation. Groups were compared by gender, age, and parameters. ROC curves evaluated prediction efficacy.

Results: Females exhibited smaller FHD, FNL, FO, TAD, TAA but larger FNSA/FNAA vs males (P<0.05). Patients >65 years had higher FO, TAD, TAA (P<0.05). TAD-TAA correlation was strong (r=0.954), while FNSA negatively correlated with TAD/TAA (r=-0.773/-0.701). ROC analysis demonstrated high predictive accuracy: TAD (AUC=0.891, sensitivity=91.7%, specificity=87.6%) and TAA (AUC=0.882, sensitivity=100%, specificity=88.8%).

Conclusion: CT parameters (TAA, TAD, FNSA, FO) are interrelated and effective predictors for femoral prosthesis selection. Integration with AI-assisted planning optimizes personalized THA, reducing biomechanical mismatch risks.

目的:探讨CT测量参数结合人工智能辅助三维规划在全髋关节置换术(THA)个体化股骨假体选择中的效果。方法:回顾性分析2021年4月至2024年2月在湖北医科大学人民医院治疗的247例单侧髋关节或膝关节疾病患者的临床资料。所有患者术前均行全骨盆和双侧全股骨CT扫描。将原始CT数据导入Mimics 19.0软件,重建健康股骨的三维(3D)模型。采用3-matic Research 11.0软件定位股骨头旋转中心,测量股骨头直径(FHD)、股骨头颈长(FNL)、股骨头颈轴角(FNSA)、股骨偏置(FO)、股骨头颈前倾角(FNAA)、股骨头尖端距离(TAD)、股骨头尖端角(TAA)等参数。采用ai辅助THA三维规划系统AIJOINT V1.0.0.0软件进行术前规划设计,实现不同颈轴角度股骨假体的个性化选择和手术模拟。各组按性别、年龄和参数进行比较。ROC曲线评价预测效果。结果:与男性相比,女性FHD、FNL、FO、TAD、TAA较小,但FNSA/FNAA较大(P65岁患者FO、TAD、TAA较高)。结论:CT参数(TAA、TAD、FNSA、FO)是股骨假体选择的相关有效预测指标。与人工智能辅助规划的集成优化了个性化THA,降低了生物力学失配风险。
{"title":"AI-Assisted 3D Planning of CT Parameters for Personalized Femoral Prosthesis Selection in Total Hip Arthroplasty.","authors":"Tian-Jiao Yang, Wei Qian","doi":"10.2147/TCRM.S521755","DOIUrl":"10.2147/TCRM.S521755","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the efficacy of CT measurement parameters combined with AI-assisted 3D planning for personalized femoral prosthesis selection in total hip arthroplasty (THA).</p><p><strong>Methods: </strong>A retrospective analysis was conducted on clinical data from 247 patients with unilateral hip or knee joint disorders treated at Renmin Hospital of Hubei University of Medicine between April 2021 and February 2024. All patients underwent preoperative full-pelvis and bilateral full-length femoral CT scans. The raw CT data were imported into Mimics 19.0 software to reconstruct a three-dimensional (3D) model of the healthy femur. Using 3-matic Research 11.0 software, the femoral head rotation center was located, and parameters including femoral head diameter (FHD), femoral neck length (FNL), femoral neck-shaft angle (FNSA), femoral offset (FO), femoral neck anteversion angle (FNAA), tip-apex distance (TAD), and tip-apex angle (TAA) were measured. AI-assisted THA 3D planning system AIJOINT V1.0.0.0 software was used for preoperative planning and design, enabling personalized selection of femoral prostheses with varying neck-shaft angles and surgical simulation. Groups were compared by gender, age, and parameters. ROC curves evaluated prediction efficacy.</p><p><strong>Results: </strong>Females exhibited smaller FHD, FNL, FO, TAD, TAA but larger FNSA/FNAA vs males (P<0.05). Patients >65 years had higher FO, TAD, TAA (P<0.05). TAD-TAA correlation was strong (r=0.954), while FNSA negatively correlated with TAD/TAA (r=-0.773/-0.701). ROC analysis demonstrated high predictive accuracy: TAD (AUC=0.891, sensitivity=91.7%, specificity=87.6%) and TAA (AUC=0.882, sensitivity=100%, specificity=88.8%).</p><p><strong>Conclusion: </strong>CT parameters (TAA, TAD, FNSA, FO) are interrelated and effective predictors for femoral prosthesis selection. Integration with AI-assisted planning optimizes personalized THA, reducing biomechanical mismatch risks.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"905-916"},"PeriodicalIF":2.8,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182742/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144476754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Application of Opacification-Development Ratio Based on CT Scan for Diagnosing Pediatric Chronic Rhinosinusitis. CT扫描混浊显影比在小儿慢性鼻窦炎诊断中的应用。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-13 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S520879
Jun Zhang, Anni Yang, Tengyu Chen, Yufeng Cao, Qiliang Lv, Yingxiang Xu, Zhenpeng Liao, Xianzhen Chen, Zhongkang Ye, Renjie Lai, Haiyu Hong

Purpose: To investigate the diagnostic potency of the opacification-development ratio (ODR) for pediatric chronic rhinosinusitis based on CT scanning.

Patients and methods: Children aged 0-15 years who underwent nasal CT scanning from August 2011 through July 2021 were included in the research. The area under receiver operating characteristic curve (AUC) and predictive value were used to assess the diagnostic accuracy of the ODR and Lund-Mackay score based on CT scanning.

Results: A total of 1820 patients (217 in the positive symptom group and 1603 in the negative symptom group) who underwent CT scanning were included in the study. A significant positive correlation was observed between the ODR and the Lund-Mackay score in all age groups. In children aged 0-15 years, the AUC of the ODR and the Lund-Mackay score were 0.7970 and 0.7719, respectively (p > 0.05). The optimal cut-off value for the ODR was 25.83, with a sensitivity of 57.14% and a specificity of 94.2%. In contrast, the optimal cut-off value for the Lund-Mackay score was 6.5, with a sensitivity of 6.5% and a specificity of 85.84%. Notably, the ODR score demonstrated significantly superior performance compared to the Lund-Mackay score in children aged 0-4 years (p < 0.001).

Conclusion: In diagnosing pediatric chronic rhinosinusitis, the use of CT scans is associated with a higher rate of false positives when compared to clinical symptoms. The ODR score based on CT scanning is a valuable diagnostic tool for chronic rhinosinusitis in children aged 0-11, particularly those aged 0-4.

目的:探讨CT扫描对儿童慢性鼻窦炎的诊断价值。患者和方法:研究纳入了2011年8月至2021年7月期间接受鼻腔CT扫描的0-15岁儿童。采用受者工作特征曲线下面积(AUC)和预测值评估CT扫描ODR和Lund-Mackay评分的诊断准确性。结果:共纳入1820例CT扫描患者(阳性症状组217例,阴性症状组1603例)。各年龄组ODR与Lund-Mackay评分呈显著正相关。0 ~ 15岁儿童的ODR和Lund-Mackay评分的AUC分别为0.7970和0.7719 (p < 0.05)。ODR最佳临界值为25.83,敏感性为57.14%,特异性为94.2%。相比之下,Lund-Mackay评分的最佳临界值为6.5,敏感性为6.5%,特异性为85.84%。值得注意的是,与Lund-Mackay评分相比,0-4岁儿童的ODR评分表现出显著优于Lund-Mackay评分(p < 0.001)。结论:在诊断儿童慢性鼻窦炎时,与临床症状相比,使用CT扫描与更高的假阳性率相关。基于CT扫描的ODR评分是0-11岁儿童特别是0-4岁儿童慢性鼻窦炎的有价值的诊断工具。
{"title":"The Application of Opacification-Development Ratio Based on CT Scan for Diagnosing Pediatric Chronic Rhinosinusitis.","authors":"Jun Zhang, Anni Yang, Tengyu Chen, Yufeng Cao, Qiliang Lv, Yingxiang Xu, Zhenpeng Liao, Xianzhen Chen, Zhongkang Ye, Renjie Lai, Haiyu Hong","doi":"10.2147/TCRM.S520879","DOIUrl":"10.2147/TCRM.S520879","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the diagnostic potency of the opacification-development ratio (ODR) for pediatric chronic rhinosinusitis based on CT scanning.</p><p><strong>Patients and methods: </strong>Children aged 0-15 years who underwent nasal CT scanning from August 2011 through July 2021 were included in the research. The area under receiver operating characteristic curve (AUC) and predictive value were used to assess the diagnostic accuracy of the ODR and Lund-Mackay score based on CT scanning.</p><p><strong>Results: </strong>A total of 1820 patients (217 in the positive symptom group and 1603 in the negative symptom group) who underwent CT scanning were included in the study. A significant positive correlation was observed between the ODR and the Lund-Mackay score in all age groups. In children aged 0-15 years, the AUC of the ODR and the Lund-Mackay score were 0.7970 and 0.7719, respectively (p > 0.05). The optimal cut-off value for the ODR was 25.83, with a sensitivity of 57.14% and a specificity of 94.2%. In contrast, the optimal cut-off value for the Lund-Mackay score was 6.5, with a sensitivity of 6.5% and a specificity of 85.84%. Notably, the ODR score demonstrated significantly superior performance compared to the Lund-Mackay score in children aged 0-4 years (p < 0.001).</p><p><strong>Conclusion: </strong>In diagnosing pediatric chronic rhinosinusitis, the use of CT scans is associated with a higher rate of false positives when compared to clinical symptoms. The ODR score based on CT scanning is a valuable diagnostic tool for chronic rhinosinusitis in children aged 0-11, particularly those aged 0-4.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"895-904"},"PeriodicalIF":2.8,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12174934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Antiviral Treatment on Survival in HBV-Related Intrahepatic Cholangiocarcinoma Patients After Hepatectomy: A 14-Year Retrospective Follow-Up Study Based on the Propensity Score Matching Method. 抗病毒治疗对肝切除术后hbv相关肝内胆管癌患者生存的影响:基于倾向评分匹配法的14年回顾性随访研究
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-11 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S520629
Zhiqiang Chen, Hui Zhang, Long Zhang, Guoyong Han, Yao Zhang, Jindao Wu, Xiangcheng Li, Xiaoxin Mu, Xuehao Wang

Purpose: Hepatitis B virus infection is one of the most common risk factors leading to the development of intrahepatic cholangiocarcinoma (ICC). This study aims to determine the impact of antiviral treatment (AVT) on the survival outcomes of ICC patients with hepatitis B virus infection.

Patients and methods: This retrospective study included ICC patients who had HBV infection and underwent hepatectomy from May 2009 to June 2023 at a single medical center. Patients' baseline characteristics were analyzed, and the 14-year follow-up data were investigated using Kaplan-Meier curves and multivariable Cox proportional hazards regression models. The propensity score matching method was performed to balance the baseline differences between the AVT group and the non-AVT group.

Results: A total of 229 patients were finally enrolled in the analysis. In the total cohort, 81 patients were classified into the AVT group and 148 patients into the non-AVT group. Kaplan-Meier curves showed that the AVT group exhibited prolonged overall survival and recurrence-free survival compared to the non-AVT group. Cox proportional hazards regression models revealed that AVT was an independent prognostic factor for both overall survival (HR 0.453, 95% CI: 0.280-0.732) and recurrence-free survival (HR 0.659, 95% CI: 0.436-0.997). A 1:1 nearest-neighbor matching algorithm was adopted, and 64 pairs of AVT and non-AVT patients were included in the propensity score matching cohort. Multivariable survival analyses confirmed AVT as a significant predictor for a favorable overall survival (HR 0.277, 95% CI: 0.147-0.519), but no statistical significance for recurrence-free survival was observed between the AVT group and the non-AVT group after propensity score matching.

Conclusion: We analyzed the long-term follow-up data for ICC patients with hepatitis B virus infection who underwent hepatectomy. Notably, AVT exhibited a beneficial impact on overall survival for these postoperative ICC patients. However, our findings indicated no statistically significant effect of AVT on recurrence-free survival.

目的:乙型肝炎病毒感染是导致肝内胆管癌(ICC)发生的最常见危险因素之一。本研究旨在确定抗病毒治疗(AVT)对合并乙型肝炎病毒感染的ICC患者生存结局的影响。患者和方法:本回顾性研究包括2009年5月至2023年6月在单一医疗中心接受HBV感染和肝切除术的ICC患者。分析患者的基线特征,并采用Kaplan-Meier曲线和多变量Cox比例风险回归模型对14年随访数据进行调查。采用倾向评分匹配法来平衡AVT组和非AVT组之间的基线差异。结果:最终共有229例患者纳入分析。在整个队列中,81例患者被分为AVT组,148例患者被分为非AVT组。Kaplan-Meier曲线显示,与非AVT组相比,AVT组的总生存期和无复发生存期延长。Cox比例风险回归模型显示,AVT是总生存率(HR 0.453, 95% CI: 0.280 ~ 0.732)和无复发生存率(HR 0.659, 95% CI: 0.436 ~ 0.997)的独立预后因素。采用1:1最近邻匹配算法,将64对AVT和非AVT患者纳入倾向评分匹配队列。多变量生存分析证实AVT是有利的总生存的重要预测因子(HR 0.277, 95% CI: 0.147-0.519),但倾向评分匹配后AVT组和非AVT组无复发生存无统计学意义。结论:我们分析了行肝切除术的ICC合并乙型肝炎病毒感染患者的长期随访资料。值得注意的是,AVT对这些术后ICC患者的总体生存有有益的影响。然而,我们的研究结果显示,AVT对无复发生存期的影响没有统计学意义。
{"title":"Impact of Antiviral Treatment on Survival in HBV-Related Intrahepatic Cholangiocarcinoma Patients After Hepatectomy: A 14-Year Retrospective Follow-Up Study Based on the Propensity Score Matching Method.","authors":"Zhiqiang Chen, Hui Zhang, Long Zhang, Guoyong Han, Yao Zhang, Jindao Wu, Xiangcheng Li, Xiaoxin Mu, Xuehao Wang","doi":"10.2147/TCRM.S520629","DOIUrl":"10.2147/TCRM.S520629","url":null,"abstract":"<p><strong>Purpose: </strong>Hepatitis B virus infection is one of the most common risk factors leading to the development of intrahepatic cholangiocarcinoma (ICC). This study aims to determine the impact of antiviral treatment (AVT) on the survival outcomes of ICC patients with hepatitis B virus infection.</p><p><strong>Patients and methods: </strong>This retrospective study included ICC patients who had HBV infection and underwent hepatectomy from May 2009 to June 2023 at a single medical center. Patients' baseline characteristics were analyzed, and the 14-year follow-up data were investigated using Kaplan-Meier curves and multivariable Cox proportional hazards regression models. The propensity score matching method was performed to balance the baseline differences between the AVT group and the non-AVT group.</p><p><strong>Results: </strong>A total of 229 patients were finally enrolled in the analysis. In the total cohort, 81 patients were classified into the AVT group and 148 patients into the non-AVT group. Kaplan-Meier curves showed that the AVT group exhibited prolonged overall survival and recurrence-free survival compared to the non-AVT group. Cox proportional hazards regression models revealed that AVT was an independent prognostic factor for both overall survival (HR 0.453, 95% CI: 0.280-0.732) and recurrence-free survival (HR 0.659, 95% CI: 0.436-0.997). A 1:1 nearest-neighbor matching algorithm was adopted, and 64 pairs of AVT and non-AVT patients were included in the propensity score matching cohort. Multivariable survival analyses confirmed AVT as a significant predictor for a favorable overall survival (HR 0.277, 95% CI: 0.147-0.519), but no statistical significance for recurrence-free survival was observed between the AVT group and the non-AVT group after propensity score matching.</p><p><strong>Conclusion: </strong>We analyzed the long-term follow-up data for ICC patients with hepatitis B virus infection who underwent hepatectomy. Notably, AVT exhibited a beneficial impact on overall survival for these postoperative ICC patients. However, our findings indicated no statistically significant effect of AVT on recurrence-free survival.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"869-884"},"PeriodicalIF":2.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12168928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144310470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Construction and Validation of Risk Scoring Model for Inadequate Bowel Preparation in Elderly Patients Undergoing Colonoscopy. 老年结肠镜检查患者肠道准备不足风险评分模型的构建与验证。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-11 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S503389
Yun Xu, Shan Ou, Xiu Yuan, Jie Yao, Tianwen Yang

Objective: To establish a prediction model for the risk of inadequate bowel preparation for colonoscopy in the elderly, and to validate the model to test its prediction effect.

Methods: A total 927 patients who underwent colonoscopy in the First Affiliated Hospital to Chongqing Medical and Pharmaceutical College from January to December 2023 were selected as the modeling group, and were divided into the success group (839 patients) and failure group (88 patients) according to whether or not inadequate bowel preparation occurred, and then a logistic regression prediction model was established and transformed into a risk scoring system. The area under the ROC curve and the Hosmer-Lemeshow test were used for model differentiation and calibration, respectively, and the 10-fold cross-validation method was used for internal validation of the model. A total of 548 patients who underwent colonoscopy in our hospital from January to June 2024 were selected for external validation of the model.

Results: Logistic regression analysis showed that age ≥65 years, diabetes mellitus, exercise habits, Bristol stool characterization scale, frailty, and ambulatory functional status were independent factors influencing the inadequate bowel preparation for colonoscopy in the elderly. The area under the ROC curve for the modeling group was 0.806, and the Hosmer-Lemeshow test showed p=0.870. The area under the ROC curve of the validation group was (0.785±0.090). The area under the ROC curve of the validation group was 0.824, and the Hosmer-Lemeshow test showed P=0.907, with a sensitivity of 73.13%, a specificity of 80.70%, and a Jordon's index of 0.538.

Conclusion: The predictive model of the risk of inadequate bowel preparation for colonoscopy in elderly people can predict the risk of inadequate bowel preparation in elderly people, and can be used as a tool for clinical caregivers to screen the high-risk group of inadequate bowel preparation in the elderly.

目的:建立老年人结肠镜准备不充分风险的预测模型,并对模型进行验证,检验其预测效果。方法:选择2023年1月至12月在重庆医学院第一附属医院行结肠镜检查的927例患者作为建模组,根据是否发生肠道准备不充分分为成功组(839例)和失败组(88例),建立logistic回归预测模型并转化为风险评分系统。分别采用ROC曲线下面积法和Hosmer-Lemeshow检验对模型进行判别和校正,采用10倍交叉验证法对模型进行内部验证。选取2024年1月至6月在我院行结肠镜检查的548例患者,对模型进行外部验证。结果:Logistic回归分析显示,年龄≥65岁、糖尿病、运动习惯、Bristol粪便特征量表、身体虚弱、移动功能状态是影响老年人结肠镜准备不足的独立因素。建模组ROC曲线下面积为0.806,Hosmer-Lemeshow检验p=0.870。验证组的ROC曲线下面积为(0.785±0.090)。验证组ROC曲线下面积为0.824,Hosmer-Lemeshow检验P=0.907,敏感性为73.13%,特异性为80.70%,jordan’s指数为0.538。结论:老年人结肠镜下肠准备不充分风险预测模型可预测老年人肠准备不充分风险,可作为临床护理人员筛查老年人肠准备不充分高危人群的工具。
{"title":"Construction and Validation of Risk Scoring Model for Inadequate Bowel Preparation in Elderly Patients Undergoing Colonoscopy.","authors":"Yun Xu, Shan Ou, Xiu Yuan, Jie Yao, Tianwen Yang","doi":"10.2147/TCRM.S503389","DOIUrl":"10.2147/TCRM.S503389","url":null,"abstract":"<p><strong>Objective: </strong>To establish a prediction model for the risk of inadequate bowel preparation for colonoscopy in the elderly, and to validate the model to test its prediction effect.</p><p><strong>Methods: </strong>A total 927 patients who underwent colonoscopy in the First Affiliated Hospital to Chongqing Medical and Pharmaceutical College from January to December 2023 were selected as the modeling group, and were divided into the success group (839 patients) and failure group (88 patients) according to whether or not inadequate bowel preparation occurred, and then a logistic regression prediction model was established and transformed into a risk scoring system. The area under the ROC curve and the Hosmer-Lemeshow test were used for model differentiation and calibration, respectively, and the 10-fold cross-validation method was used for internal validation of the model. A total of 548 patients who underwent colonoscopy in our hospital from January to June 2024 were selected for external validation of the model.</p><p><strong>Results: </strong>Logistic regression analysis showed that age ≥65 years, diabetes mellitus, exercise habits, Bristol stool characterization scale, frailty, and ambulatory functional status were independent factors influencing the inadequate bowel preparation for colonoscopy in the elderly. The area under the ROC curve for the modeling group was 0.806, and the Hosmer-Lemeshow test showed p=0.870. The area under the ROC curve of the validation group was (0.785±0.090). The area under the ROC curve of the validation group was 0.824, and the Hosmer-Lemeshow test showed <i>P</i>=0.907, with a sensitivity of 73.13%, a specificity of 80.70%, and a Jordon's index of 0.538.</p><p><strong>Conclusion: </strong>The predictive model of the risk of inadequate bowel preparation for colonoscopy in elderly people can predict the risk of inadequate bowel preparation in elderly people, and can be used as a tool for clinical caregivers to screen the high-risk group of inadequate bowel preparation in the elderly.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"885-894"},"PeriodicalIF":2.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12168974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144310469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Muscular and Renal Safety of Ticagrelor with High-Intensity Statins: Retrospective Cohort Findings. 替格瑞洛与高强度他汀类药物的肌肉和肾脏安全性:回顾性队列研究结果。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2025-06-08 eCollection Date: 2025-01-01 DOI: 10.2147/TCRM.S515732
Abdullah S Alshammari, Amer A Shalwala, Mohammed A Alnuhait, Abdulfattah Y Alhazmi, Refal E Fagieha, Nura Bin Hallabi, Eyad A Alandijani, Mansour A Aloufi, Mudhhi S Alharbi, Reem S Alzahrani, Emad M Elkholy, Mahmoud E Elrggal, Abdulmalik S Alotaibi

Introduction: Ticagrelor is a widely used antiplatelet agent approved in over 70 countries, including the European Union and the United States, for reducing thrombotic events in patients with acute coronary syndromes (ACS). In clinical practice, combining ticagrelor with high-intensity statins is considered standard therapy for ACS. However, recent pharmacodynamic studies and case reports suggest potential drug-drug interactions that may increase the risk of adverse events, particularly muscular and renal complications. This study aimed to evaluate these risks in a real-world clinical setting in Saudi Arabia.

Methods: This retrospective observational cohort study was conducted at the Makkah Cardiology Center, Saudi Arabia. The study included adult patients (n = 577) who were prescribed high-intensity statins, with or without concurrent ticagrelor. The primary outcomes were the incidence of statin-associated muscular complications-defined as myalgia, myopathy, myositis, or rhabdomyolysis-and acute kidney injury (AKI). Clinical data were extracted from the hospital information system, and statistical comparisons were conducted between patients receiving statin monotherapy and those receiving combination therapy.

Results: The cohort consisted predominantly of male patients (74.5%). Muscle-related complications were significantly more common in the group receiving both ticagrelor and statins (20.2%) compared to the statin-only group (10.5%) (P = 0.001). Among comorbid conditions, hypertension was the only factor significantly associated with a higher incidence of muscle-related complications. Although a trend toward increased AKI incidence was observed in the combination therapy group, this difference did not reach statistical significance.

Conclusion: This study highlights potential safety concerns related to the co-administration of ticagrelor and high-intensity statins, particularly the increased risk of muscle-related complications. While the findings on AKI were inconclusive, the results support the need for cautious use of this combination and call for larger prospective studies to further evaluate its safety profile and optimize treatment strategies.

替格瑞洛是一种广泛使用的抗血小板药物,已在包括欧盟和美国在内的70多个国家获得批准,用于减少急性冠脉综合征(ACS)患者的血栓形成事件。在临床实践中,替格瑞洛联合高强度他汀类药物被认为是ACS的标准治疗方法。然而,最近的药效学研究和病例报告表明,潜在的药物-药物相互作用可能增加不良事件的风险,特别是肌肉和肾脏并发症。本研究旨在评估沙特阿拉伯现实世界临床环境中的这些风险。方法:本回顾性观察队列研究在沙特阿拉伯的麦加心脏病学中心进行。该研究纳入成人患者(n = 577),他们服用高强度他汀类药物,同时服用或不服用替格瑞洛。主要结局是他汀类药物相关肌肉并发症(定义为肌痛、肌病、肌炎或横纹肌溶解)和急性肾损伤(AKI)的发生率。从医院信息系统中提取临床资料,对接受他汀类药物单一治疗与联合治疗的患者进行统计比较。结果:该队列以男性患者为主(74.5%)。肌肉相关并发症在同时接受替格瑞洛和他汀类药物治疗组(20.2%)比仅接受他汀类药物治疗组(10.5%)更为常见(P = 0.001)。在合并症中,高血压是唯一与肌肉相关并发症发生率升高显著相关的因素。虽然在联合治疗组中观察到AKI发病率增加的趋势,但这种差异没有达到统计学意义。结论:本研究强调了替格瑞洛和高强度他汀类药物联合使用的潜在安全性问题,特别是肌肉相关并发症的风险增加。虽然AKI的研究结果尚无定论,但结果支持谨慎使用该组合的必要性,并呼吁进行更大规模的前瞻性研究,以进一步评估其安全性并优化治疗策略。
{"title":"Muscular and Renal Safety of Ticagrelor with High-Intensity Statins: Retrospective Cohort Findings.","authors":"Abdullah S Alshammari, Amer A Shalwala, Mohammed A Alnuhait, Abdulfattah Y Alhazmi, Refal E Fagieha, Nura Bin Hallabi, Eyad A Alandijani, Mansour A Aloufi, Mudhhi S Alharbi, Reem S Alzahrani, Emad M Elkholy, Mahmoud E Elrggal, Abdulmalik S Alotaibi","doi":"10.2147/TCRM.S515732","DOIUrl":"10.2147/TCRM.S515732","url":null,"abstract":"<p><strong>Introduction: </strong>Ticagrelor is a widely used antiplatelet agent approved in over 70 countries, including the European Union and the United States, for reducing thrombotic events in patients with acute coronary syndromes (ACS). In clinical practice, combining ticagrelor with high-intensity statins is considered standard therapy for ACS. However, recent pharmacodynamic studies and case reports suggest potential drug-drug interactions that may increase the risk of adverse events, particularly muscular and renal complications. This study aimed to evaluate these risks in a real-world clinical setting in Saudi Arabia.</p><p><strong>Methods: </strong>This retrospective observational cohort study was conducted at the Makkah Cardiology Center, Saudi Arabia. The study included adult patients (n = 577) who were prescribed high-intensity statins, with or without concurrent ticagrelor. The primary outcomes were the incidence of statin-associated muscular complications-defined as myalgia, myopathy, myositis, or rhabdomyolysis-and acute kidney injury (AKI). Clinical data were extracted from the hospital information system, and statistical comparisons were conducted between patients receiving statin monotherapy and those receiving combination therapy.</p><p><strong>Results: </strong>The cohort consisted predominantly of male patients (74.5%). Muscle-related complications were significantly more common in the group receiving both ticagrelor and statins (20.2%) compared to the statin-only group (10.5%) (P = 0.001). Among comorbid conditions, hypertension was the only factor significantly associated with a higher incidence of muscle-related complications. Although a trend toward increased AKI incidence was observed in the combination therapy group, this difference did not reach statistical significance.</p><p><strong>Conclusion: </strong>This study highlights potential safety concerns related to the co-administration of ticagrelor and high-intensity statins, particularly the increased risk of muscle-related complications. While the findings on AKI were inconclusive, the results support the need for cautious use of this combination and call for larger prospective studies to further evaluate its safety profile and optimize treatment strategies.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"861-867"},"PeriodicalIF":2.8,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12161285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutics and Clinical Risk Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1